Bibliographic citations
This is an automatically generated citacion. Modify it if you see fit
Herrera, L., (2022). Vacuna contra la influenza como factor predisponente del síndrome de Guillian-Barre [Tesis, Universidad Privada Antenor Orrego - UPAO]. https://hdl.handle.net/20.500.12759/9620
Herrera, L., Vacuna contra la influenza como factor predisponente del síndrome de Guillian-Barre [Tesis]. PE: Universidad Privada Antenor Orrego - UPAO; 2022. https://hdl.handle.net/20.500.12759/9620
@misc{renati/372573,
title = "Vacuna contra la influenza como factor predisponente del síndrome de Guillian-Barre",
author = "Herrera Alvitres, Luis Miguel",
publisher = "Universidad Privada Antenor Orrego - UPAO",
year = "2022"
}
Title: Vacuna contra la influenza como factor predisponente del síndrome de Guillian-Barre
Authors(s): Herrera Alvitres, Luis Miguel
Advisor(s): Tresierra Ayala, Miguel Ángel
OCDE field: http://purl.org/pe-repo/ocde/ford#3.02.27
Issue Date: 2022
Institution: Universidad Privada Antenor Orrego - UPAO
Abstract: Se llevó a cabo una revisión sistemática, para estudiar la vacuna contra
la influenza como factor predisponente del síndrome de Guillain-Barré en la
población vacunada frente a los no vacunados en estudios observacionales.
Material y métodos: Se realizó la búsqueda en las bases de datos de MedLine
(PubMed), Scopus y Web of Science desde Diciembre del 2021 hasta Enero del
2022; sin aplicar filtro alguno a la información obtenida. Se incluyó estudios
observacionales de cohorte, casos y controles o ambos, que estudiaron la
aplicación de la vacuna contra la influenza y la instauración del síndrome de
Guillain-Barré. El sesgo de cada estudio fue evaluado por la Escala de
Newcastle-Ottawa, aceptándose únicamente estudios de bajo riesgo.
Resultados: Un total de 5 estudios de casos y controles fueron incluidos,
conformándose grupos de 2 346 casos y 20 825 controles. La síntesis
meta-analítica en Odds Ratio es de 1,93 (IC al 95%: 0,93 a 4,02) y la dirección del
efecto tiende a favorecer el evento de manera no significativa.
Conclusiones: La evidencia obtenida muestra la no asociación entre la vacuna
contra la influenza y la predisposición para la instauración del síndrome de
Guillain-Barré. Más estudios son necesarios. Los autores no lograron garantizar el
acceso a la base de datos EMBASE y tampoco realizaron búsqueda de la
literatura gris. La inclusión de estudios de bajo riesgo otorga una alta calidad a la
información sintetizada en este estudio.
A systematic review was performed to study the influenza vaccine as a predisposing factor for Guillain-Barre syndrome in the vaccinated population against the unvaccinated population in observational studies. Materials and methods: The search was carried out in the MedLine (PubMed), Scopus and Web of Science databases from December 2021 to January 2022; without applying any filter to the information obtained. Observational cohort studies, case-control studies or both, that studied the application of the influenza vaccine and the development of Guillain-Barré syndrome were included. The bias of each study was evaluated by the Newcastle-Ottawa Scale, accepting only low-risk studies. Results: A total of 5 case-control studies were included, with groups of 2 346 cases and 20 825 controls. The meta-analytical synthesis in Odds Ratio is 1.93 (95% CI: 0.93 to 4.02) and the direction of the effect tends to favor the event in a non-significant way. Conclusions: The evidence obtained shows no association between the Influenza vaccine and the predisposition for the development of Guillain-Barré syndrome. More studies are needed. The authors were unable to secure access to the EMBASE database and did not search the gray literature. The inclusion of low-risk studies gives high quality to the information synthesized in this study.
A systematic review was performed to study the influenza vaccine as a predisposing factor for Guillain-Barre syndrome in the vaccinated population against the unvaccinated population in observational studies. Materials and methods: The search was carried out in the MedLine (PubMed), Scopus and Web of Science databases from December 2021 to January 2022; without applying any filter to the information obtained. Observational cohort studies, case-control studies or both, that studied the application of the influenza vaccine and the development of Guillain-Barré syndrome were included. The bias of each study was evaluated by the Newcastle-Ottawa Scale, accepting only low-risk studies. Results: A total of 5 case-control studies were included, with groups of 2 346 cases and 20 825 controls. The meta-analytical synthesis in Odds Ratio is 1.93 (95% CI: 0.93 to 4.02) and the direction of the effect tends to favor the event in a non-significant way. Conclusions: The evidence obtained shows no association between the Influenza vaccine and the predisposition for the development of Guillain-Barré syndrome. More studies are needed. The authors were unable to secure access to the EMBASE database and did not search the gray literature. The inclusion of low-risk studies gives high quality to the information synthesized in this study.
Link to repository: https://hdl.handle.net/20.500.12759/9620
Discipline: Medicina
Grade or title grantor: Universidad Privada Antenor Orrego. Facultad de Medicina Humana
Grade or title: Medico Cirujano
Juror: Vásquez Tirado, Gustavo Adolfo; Obesso Uribe, Myriam Devaki; Díaz Camacho, Pedro Segundo
Register date: 26-Oct-2022
This item is licensed under a Creative Commons License